HOWDEN JOINERY GRP LS-,10/ GB0005576813 /
04/06/2024 11:14:34 | Chg. - | Volume | Bid22:00:08 | Ask22:00:08 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
10.70EUR | - | 285 Turnover: 3,049.50 |
10.47Bid Size: 488 | 10.64Ask Size: 479 | 5.71 bill.EUR | - | - |
GlobeNewswire
01:15
Crown Crafts to Announce Fourth Quarter and Full Year Fiscal 2024 Results on June 28, 2024
GlobeNewswire
01:10
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAN, RPHM on Behalf of Shareholders
GlobeNewswire
00:45
Teladoc Health is Providing Free Virtual Health Care Services to New Mexico Residents Impacted by Wi...
GlobeNewswire
00:38
Toyota Announcement: If You Have Suffered Losses in Toyota Motor Corporation (NYSE: TM), You Are Enc...
GlobeNewswire
00:30
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-...
GlobeNewswire
00:24
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against UiPath, Inc. (...
GlobeNewswire
00:00
KIP Protocol Partners with Open Campus to Launch Open Campus U, Transforming Education Through Decen...
GlobeNewswire
21/06
Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest C...
GlobeNewswire
21/06
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against NIKE, Inc. (NK...
GlobeNewswire
21/06
NIKE, INC. (NYSE: NIKE) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Act...
GlobeNewswire
21/06
Metasphere Labs Enters a Definitive Agreement with ARCannabis to Develop VR Virtual Store
GlobeNewswire
21/06
In Major Victory For Injured Owners of “Dangerously Defective” Firearm, Federal Jury Awards $2.35 Mi...
GlobeNewswire
21/06
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
21/06
Goodness Growth Holdings Announces Voting Results of Annual General and Special Meeting of Sharehold...
GlobeNewswire
21/06
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropat...